EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ENSEM was filed as Word mark on 05/24/2024 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/03/2024.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 019031818 |
| Application date | May 24, 2024 |
| Publication date | June 26, 2024 |
| Entry date | October 3, 2024 |
| Expiration date | May 24, 2034 |
Trademark owner
880 Winter Street, Suite 1003
02451 Waltham, MA
US
02451 Waltham, MA
US
Trademark representatives
Fasanenstr. 29
10719 Berlin
DE
goods and services
5
Pharmaceutical preparations; Pharmaceutical preparations for the treatment of cancer; Drug delivery agents in particular targeted medicines that deliver chemotherapeutical agents to cancer cells: Drugs for medical purposes in particular cancer drugs; Pharmaceuticals comprising small molecule compounds for medical use and drug delivery; Small molecule pharmaceuticals for the treatment of diseases and conditions in particular cancer; Pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders; Diagnostic preparations for medical purposes in particular for the diagnosis of cancer; Biological substances for human medical diagnostics and analysis
9
Computer software using in particular artificial intelligence for medical purposes, namely, conducting drug research; Computer software using artificial intelligence for the identification of cryptic pockets on macromolecules and target compounds for precision medicine approaches to drug discovery; Computer software using artificial intelligence for developing small molecules for oncology; Computer software for the analysis of biological assays, antigen detection assays and antibody assays, structural compound simulation; Bioinformatics software for genome and transcriptome sequence analysis; Bioinformatics software; Cheminformatics software; Software for analyzing and predicting drug target interactions
42
Artificial intelligence technology consultancy in the field of drug research; Research in the field of artificial intelligence in particular for drug research; Technology consultation in the field of medical artificial intelligence; Research in the field of medical artificial intelligence technology; Platforms for artificial intelligence as software as a medical service, namely, conducting drug discovery of candidate molecules; Computer software platforms for medical artificial intelligence; Scientific and research services; Bioinformatic services; Therapeutic research; Pharmaceutical research; Drug discovery services; Pharmaceutical drug development services; Biological research; Clinical research in the medical, pharmaceutical, and biotechnology fields; Medical research; Research on the subject of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical products development; Medical laboratory services relating to the production of monoclonal antibodies; biomedical research services; Medical and scientific research in the field of pharmacogenetics; Research and development in the field of therapeutics in particular cancer therapeutics; Scientific services relating to therapeutic development in particular cancer therapeutic development; Biotechnological research; Biotechnology testing; Pharmaceutical formulation product development; Developments of pharmaceutical formulations and active pharmaceutical ingredients
ID: 11019031818